Deutsche Bank
BHVN

Deutsche Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Deutsche Bank’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-53,372
Closed -$8.07M – 4175
2022
Q3 		$8.07M Sell
53,372
-45,560
-46% -$6.75M ﹤0.01% 1028
2022
Q2 		$14.4M Sell
98,932
-671,935
-87% -$85.8M 0.01% 873
2022
Q1 		$91.4M Sell
770,867
-27,113
-3% -$3.38M 0.04% 398
2021
Q4 		$110M Buy
797,980
+60,009
+8% +$7.63M 0.05% 360
2021
Q3 		$103M Sell
737,971
-16,323
-2% -$2.04M 0.05% 356
2021
Q2 		$73.2M Buy
754,294
+27,614
+4% +$2.24M 0.04% 475
2021
Q1 		$49.7M Buy
726,680
+609,527
+520% +$49.3M 0.03% 589
2020
Q4 		$10M Sell
117,153
-410,537
-78% -$34.8M 0.01% 1035
2020
Q3 		$34.3M Sell
527,690
-82,957
-14% -$5.44M 0.02% 556
2020
Q2 		$44.6M Buy
610,647
+44,314
+8% +$2.36M 0.03% 468
2020
Q1 		$19.3M Buy
566,333
+73,576
+15% +$3.36M 0.02% 666
2019
Q4 		$26.8M Buy
492,757
+399,876
+431% +$19.8M 0.02% 678
2019
Q3 		$3.87M Sell
92,881
-53,470
-37% -$2.26M ﹤0.01% 1527
2019
Q2 		$6.41M Sell
146,351
-147,244
-50% -$8.3M ﹤0.01% 1647
2019
Q1 		$15.1M Buy
293,595
+108,829
+59% +$4.7M 0.01% 1126
2018
Q4 		$6.83M Sell
184,766
-80,244
-30% -$2.89M ﹤0.01% 1543
2018
Q3 		$9.95M Buy
265,010
+64,725
+32% +$2.38M 0.01% 1638
2018
Q2 		$7.92M Buy
200,285
+138,507
+224% +$4.39M ﹤0.01% 1938
2018
Q1 		$1.59M Buy
61,778
+38,198
+162% +$1.14M ﹤0.01% 3017
2017
Q4 		$635K Buy
23,580
+5,248
+29% +$144K ﹤0.01% 3482
2017
Q3 		$683K Buy
18,332
+5,201
+40% +$158K ﹤0.01% 3245
2017
Q2 		$326K Buy
+13,131
New +$302K ﹤0.01% 3677

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Deutsche Bank's BHVN Position: Q4 2022 in Review

Deutsche Bank sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 53,372 shares — an estimated $8.07M sold.

Deutsche Bank first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $110M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Deutsche Bank reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Deutsche Bank sold 53,372 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $8.07M.
  • Deutsche Bank first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Deutsche Bank's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $110M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.